Can Fite Biopharma Ltd (NYSE American:CANF)

1.54
Delayed Data
As of Oct 22
 -0.03 / -1.91%
Today’s Change
1.48
Today|||52-Week Range
4.39
-13.48%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Can Fite Biopharma Ltd have a median target of 7.00, with a high estimate of 9.00 and a low estimate of 5.00. The median estimate represents a +354.55% increase from the last price of 1.54.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Can Fite Biopharma Ltd. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.07
Sales
$140.0K
Reporting Date
Dec 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 41.67%
 
 
 
 
 
 
Growthannually 72.09%
 
 
 
 
 
 

Sales

Growthquarterly -44.00%
 
 
 
 
 
 
Growthannually -11.80%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.